A human respiratory syncytial virus (RSV) Primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

Journal of Infectious Diseases

Volumn 167, Issue 3, 1993, Pages 553-561

  Kakuk, Thomas J ^a,b   Soike, Kenneth ^a,b   Brideau, Roger J ^a,b   Zaya, Renee M ^a,b   Cole, Serena L ^a,b   Zhang, J Y ^a,b   Roberts, E Donald ^a,b   Wells, Peter A ^a,b   Wathen, Michael W ^a,b  

^a PFIZER INC   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERCOPITHECIDAE; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; LUNG INFECTION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ANIMAL; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FORMALDEHYDE; LUNG; LUNG DISEASES; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS INFECTIONS; TIME FACTORS; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 0027393904     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/167.3.553     Document Type: Article

References (25)

1. Chanock RM, Kim HW, Brandt CD, Parrott RH, Respiratory syncytial virus, In: Evans AS, ed, Viral infections of humans, New York: Plenum, 1976: 365-82.
2. Glezen WP, Taber LH, Frank AL, Kasil JA, Risk of primary infection and reinfection with respiratory syncytial virus, Am J Dis Child 1986; 140: 543-6.
3. Heilman C, Respiratory syncytial and parainfluenza viruses, J Infect Dis 1990; 161: 402-6.
4. Anderson U, Parker RA, Strikas RL, Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths ofinfants and young children, J Infect Dis 1990; 161: 640-6.
5. Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH, Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population, Am J Epidemiol 1969; 89: 449-63.
6. Kapikian AZ, Mitchell RH, Chanock RM, Schvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine, Am J Epidemiol 1969; 89: 405-21.
7. Kim H, Canchola JG, Brandt CD, Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, Am J Epidemiol 1969; 89: 422-34.
8. Wathen MW, Kakuk TJ, Brideau RJ, Hausknecht EC, Cole SL, Zaya RM, Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge, J Infect Dis 1991; 163: 477-82.
9. Prince GA, Henson AB, Hemming VG, Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus, J Virol 1986; 57: 721-8.
10. Prince GA, Jenson AB, Horswood RL, Camargo E, Chanock RM, The pathogenesis of respiratory syncytial virus infection in cotton rats, Am J Pathol 1978; 93: 771-83.
11. Gruber C, Levine S, Respiratory syncytial virus polypeptides, 111, The envelope-associated proteins, J Gen Virol 1983; 64: 825-32.
12. Levine S, Klaiber-Franco R, Paradiso PR. Demonstration that glyc-oprotein G is the attachment protein of respiratory syncytial virus, J Gen Virol 1987; 68: 2521-4.
13. Levine S, Dajani A, Klaiber-Franco R, The response of infants with bronchiolitis to proteins of respiratory syncytial virus, J Gen Virol 1988; 69: 1229-39.
14. Olmsted RA, Elango N, Prince GA, Expression ofthe F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity, Proc Natl Acad Sci USA 1986; 83: 7462-6.
15. Walsh EE, Hall CB, Briselli M, Brandriss MW, Schlesinger JJ, Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection, J Infect Dis 1987; 155: 1198-204.
16. Wathen MW, Brideau RJ, Thomsen DR, Murphy BR, Characterization ofa novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector, J Gen Virol 1989; 70: 2625-35.
17. Brideau RJ, Walters RR, Steir MA, Wathen MW, Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein, J Gen Virol 1989; 70: 2637-44.
18. Brideau RJ, Wathen MW, A chimeric glycoprotein of human respiratory syncytial virus termed FG induces T-cell mediated immunity in mice, Vaccine 1991; 9: 863-4.
19. Belshe RB, Richardson LS, London WT, Experimental respiratory syncytial virus infection offour species of primates, J Med Virol 1977; 1: 157-62.
20. Richardson LS, Belshe RB, London WT, Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates, I, Viral shedding, immunologic response, and associated illness, J Med Virol 1978; 3: 91-100.
21. Roberts ED, Kakuk TJ, Zhang JY, Soike K, Wathen MW, Human respiratory syncytial virus (RSV) pneumonia in African green monkeys (Cercopithecus aethiops): an animal model, Vet Pathol (in press).
22. Maiorella B, Inlow O, Shanger A, Harano D, Large-scale insect cell-culture for recombinant protein production, Biotechnology 1988; 6: 1406-10.
23. Wathen MW, Brideau RJ, Thomsen DR, Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector, J Infect Dis 1989; 159: 255-63.
24. Olmsted RA, Buller RML, Collins PL, Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus, Vaccine 1988; 6: 519-24.
25. Piedra PA, Faden HS, Camussi G, Wong DT, Ogra PL, Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus, Vaccine 1989; 7: 34-8.